309 related articles for article (PubMed ID: 35874757)
21. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
[TBL] [Abstract][Full Text] [Related]
22. Drug Delivery with Extracellular Vesicles: From Imagination to Innovation.
de Jong OG; Kooijmans SAA; Murphy DE; Jiang L; Evers MJW; Sluijter JPG; Vader P; Schiffelers RM
Acc Chem Res; 2019 Jul; 52(7):1761-1770. PubMed ID: 31181910
[TBL] [Abstract][Full Text] [Related]
23. Targeted Nanoparticle Drug Delivery System for the Enhancement of Cancer Immunotherapy.
Zhang H; Wu Y; Hu Y; Li X; Zhao M; Lv Z
J Biomed Nanotechnol; 2019 Sep; 15(9):1839-1866. PubMed ID: 31387674
[TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicles-based drug delivery systems for cancer immunotherapy.
Yong T; Li X; Wei Z; Gan L; Yang X
J Control Release; 2020 Dec; 328():562-574. PubMed ID: 32946875
[TBL] [Abstract][Full Text] [Related]
25. Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.
Li L; Miao Q; Meng F; Li B; Xue T; Fang T; Zhang Z; Zhang J; Ye X; Kang Y; Zhang X; Chen Q; Liang X; Chen H; Zhang X
Theranostics; 2021; 11(12):6033-6043. PubMed ID: 33897897
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral vectors in cancer immunotherapy.
Oldham RA; Berinstein EM; Medin JA
Immunotherapy; 2015; 7(3):271-84. PubMed ID: 25804479
[TBL] [Abstract][Full Text] [Related]
27. Surface Modification of Bacteria to Optimize Immunomodulation for Advanced Immunotherapy.
Xue K; Wang L; Liu J
ChemMedChem; 2023 Feb; 18(3):e202200574. PubMed ID: 36376260
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Macrophage-Mediated Drug Delivery Systems.
Liang T; Zhang R; Liu X; Ding Q; Wu S; Li C; Lin Y; Ye Y; Zhong Z; Zhou M
Int J Nanomedicine; 2021; 16():2703-2714. PubMed ID: 33854316
[TBL] [Abstract][Full Text] [Related]
29. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Zhou L; Zhang P; Wang H; Wang D; Li Y
Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
[TBL] [Abstract][Full Text] [Related]
30. Polymer-based hydrogels with local drug release for cancer immunotherapy.
Xie Z; Shen J; Sun H; Li J; Wang X
Biomed Pharmacother; 2021 May; 137():111333. PubMed ID: 33571834
[TBL] [Abstract][Full Text] [Related]
31. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles.
Wang J; Zhu M; Nie G
Adv Drug Deliv Rev; 2021 Nov; 178():113974. PubMed ID: 34530015
[TBL] [Abstract][Full Text] [Related]
32. Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines.
Kim OY; Lee J; Gho YS
Semin Cell Dev Biol; 2017 Jul; 67():74-82. PubMed ID: 27916566
[TBL] [Abstract][Full Text] [Related]
33. A low-intensity focused ultrasound-assisted nanocomposite for advanced triple cancer therapy: local chemotherapy, therapeutic extracellular vesicles and combined immunotherapy.
Tan M; Chen Y; Guo Y; Yang C; Liu M; Guo D; Wang Z; Cao Y; Ran H
Biomater Sci; 2020 Dec; 8(23):6703-6717. PubMed ID: 33108411
[TBL] [Abstract][Full Text] [Related]
34. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
35. Cellular Membrane Components-Mediated Cancer Immunotherapeutic Platforms.
Yun S; Kim S; Kim K
Macromol Biosci; 2023 Nov; 23(11):e2300159. PubMed ID: 37319369
[TBL] [Abstract][Full Text] [Related]
36. Engineering nanoparticle strategies for effective cancer immunotherapy.
Yoon HY; Selvan ST; Yang Y; Kim MJ; Yi DK; Kwon IC; Kim K
Biomaterials; 2018 Sep; 178():597-607. PubMed ID: 29576282
[TBL] [Abstract][Full Text] [Related]
37. Bacteriosomes as a Promising Tool in Biomedical Applications: Immunotherapy and Drug Delivery.
Harisa GI; Sherif AY; Youssof AME; Alanazi FK; Salem-Bekhit MM
AAPS PharmSciTech; 2020 Jun; 21(5):168. PubMed ID: 32514657
[TBL] [Abstract][Full Text] [Related]
38. Leveraging Engineering of Cells for Drug Delivery.
Chen Z; Hu Q; Gu Z
Acc Chem Res; 2018 Mar; 51(3):668-677. PubMed ID: 29446615
[TBL] [Abstract][Full Text] [Related]
39. Bacterial extracellular vesicle applications in cancer immunotherapy.
Suri K; D'Souza A; Huang D; Bhavsar A; Amiji M
Bioact Mater; 2023 Apr; 22():551-566. PubMed ID: 36382022
[TBL] [Abstract][Full Text] [Related]
40. Generating Giant Membrane Vesicles from Live Cells with Preserved Cellular Properties.
Liu Q; Bi C; Li J; Liu X; Peng R; Jin C; Sun Y; Lyu Y; Liu H; Wang H; Luo C; Tan W
Research (Wash D C); 2019; 2019():6523970. PubMed ID: 31549076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
